Kazakhstan, Hong Kong ‘can build biotech unicorns by linking talent and capital’

Kazakhstan and Hong Kong could partner to build biotech unicorns – private start-ups valued at US$1 billion or more – by linking the Central Asian country’s strong tech workforce with the city’s global financial network, a top academic has said. Huck-Hui Ng, dean of the school of medicine at Kazakhs

HK24H 僅展示標題與短摘要，全文版權歸 SCMP Hong Kong 所有。